Quidel Culture Tube Supplies

The Virginia Indefinite Delivery Vehicle (IDV) CTR028147 provides a comprehensive procurement platform for specialized biological and cell culture materials, primarily targeting scientific research and laboratory applications. The IDV enables the acquisition of diverse research-grade products, including Zero-Serum Refeed Medium, MRC-5 Cells, Tube Cultures, R-Mix Samples, A549 Tubes, RHMK Tubes with Antiserum, and Hep2 Tubes. These materials are designed to support immunological, cellular, and scientific research processes, with precise specifications and delivery requirements for research facilities.

The master IDV is administered by the Virginia Department of General Services and is awarded to QuidelOrtho Sales Company LLC, with a contract performance period from June 11, 2025, to June 10, 2026. The contract covers statewide procurement within Virginia and appears to be a specialized supply vehicle for scientific and medical research institutions. While specific total contract value details are limited, the IDV supports targeted, specialized material acquisitions with specific delivery instructions and precise product specifications.

Under this IDV, two primary contract awards have been identified, both to Quidel Corporation. The first award (PO05006413) involves two units of Zero-Serum Refeed Medium with a minimal value of fifty-five dollars. The second and more substantial award (PO04997833) encompasses a broader range of materials, totaling 1,407 units with a cumulative value of $4,210.29. These awards demonstrate the IDV's flexibility in supporting varied research material procurement needs, with line items ranging from 3 to 480 units and unit prices between $2.14 and $38.71, tailored to specific research requirements.